Skip Navigation
Explore our COVID-19 Resources and Updates
CHS blue logo square
Home > Our Work > All Publications > 2002


Our publications keep professionals working across the public, private, and academic sectors informed on the most important developments and issues in health security and biosecurity.

Find an article or report by keywords:

Find an article or report or see all by area, author, or year:


Management of Anthrax

John G. Bartlett, Thomas V. Inglesby, Jr., Luciana Borio
Date posted:
October 01, 2002
Publication type:

Clin Infect Dis 2002 Oct 1;35(7):851-858

Oxford University Press
Available on publisher's website
See also:

Full article as HTML • PDF


 From 3 October 2001 through 16 November 2001, in the United States, there were 18 confirmed cases of inhalational and cutaneous anthrax, an additional 4 suspected cases of cutaneous anthrax, and 5 deaths due to inhalational anthrax. Although the number of cases was relatively small, this experience brought bioterrorism and its potential to sharp focus as thousands of people began receiving prophylactic antibiotics after possible exposure to anthrax spores. These events have resulted in a substantial impact on the health care system, including the rewriting of pneumonia guidelines, new emphasis on identification of microbial etiology, substantial infusion of funds for bioterrorism-related research, and a sudden mandate for regional disaster and public health planning. This article provides clinicians with clinically relevant  information about the diagnosis and management of anthrax.

Full article as HTML • PDF



Our Mission

To protect people’s health from epidemics and disasters and ensure that communities are resilient to major challenges.